We are live on
!
Find out more
FCM
Frontier Capital Management Portfolio holdings
AUM
$9.73B
1-Year Est. Return
55.65%
This Fund
S&P 500
This Quarter
Est. Return
+3.02%
1 Year Est. Return
+55.65%
3 Year Est. Return
+154.46%
5 Year Est. Return
+213.15%
10 Year Est. Return
+1,202.39%
AUM
$12.7B
AUM Growth
-$928M
(-6.8%)
Cap. Flow
-$911M
Cap. Flow
% of AUM
-7.16%
Top 10 Holdings %
Top 10 Hldgs %
17.78%
Holding
297
New
13
Increased
71
Reduced
196
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$80.6M |
| 2 |
CMRC
Commerce.com Inc Series 1
CMRC
|
+$63.3M |
| 3 |
Leslie's
LESL
|
+$56.5M |
| 4 |
Chewy
CHWY
|
+$49.2M |
| 5 |
Array Technologies
ARRY
|
+$48.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$135M |
| 2 |
Twilio
TWLO
|
+$80.6M |
| 3 |
FIVE9
FIVN
|
+$76.2M |
| 4 |
FMC
FMC
|
+$65.4M |
| 5 |
Steris
STE
|
+$63.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.44% |
| 2 | Consumer Discretionary | 19.11% |
| 3 | Healthcare | 16.78% |
| 4 | Financials | 13.41% |
| 5 | Industrials | 13.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTST
251
NETSTREIT Corp
NTST
$2.09B
| $5.96M | 0.05% |
252,003
-6,801
| -3% | -$172K |
|
252
AngioDynamics
ANGO
$611M
| $5.92M | 0.05% |
228,380
+52,970
| +30% | +$1.42M |
|
|
ABMD
253
DELISTED
Abiomed Inc
ABMD
| $5.92M | 0.05% |
18,197
-576
| -3% | -$195K |
|
254
Alamos Gold
AGI
$11.6B
| $5.8M | 0.05% |
806,012
-21,733
| -3% | -$167K |
|
|
MODN
255
DELISTED
MODEL N, INC.
MODN
| $5.37M | 0.04% |
160,422
-51,089
| -24% | -$1.73M |
|
|
NARI
256
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $5.09M | 0.04% |
62,818
+4,241
| +7% | +$356K |
|
|
SGEN
257
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.94M | 0.04% |
29,089
-239,501
| -89% | -$37.3M |
|
258
Amphastar Pharmaceuticals
AMPH
$879M
| $4.86M | 0.04% |
255,813
+70,834
| +38% | +$1.39M |
|
259
Trupanion
TRUP
$1.07B
| $4.75M | 0.04% |
61,092
-1,644
| -3% | -$162K |
|
|
GBT
260
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.58M | 0.04% |
179,806
-160,626
| -47% | -$4.72M |
|
|
AERI
261
DELISTED
Aerie Pharmaceuticals
AERI
| $4.55M | 0.04% |
399,103
-10,776
| -3% | -$158K |
|
262
Vericel Corp
VCEL
$2.35B
| $4.35M | 0.03% |
89,148
-28,408
| -24% | -$1.47M |
|
|
VIEW
263
DELISTED
View, Inc. Class A Common Stock
VIEW
| $4.23M | 0.03% |
+13,013
| New | +$4.57M |
|
264
Kirby Corp
KEX
$7.01B
| $4.19M | 0.03% |
87,420
-2,362
| -3% | -$131K |
|
265
Under Armour Class C
UA
$2.77B
| $3.25M | 0.03% |
185,596
-590,172
| -76% | -$11.3M |
|
266
Brixmor Property Group
BRX
$9.67B
| $3.14M | 0.02% |
141,871
-34,895
| -20% | -$801K |
|
267
Ouster
OUST
$2.63B
| $2.41M | 0.02% |
32,901
-43,330
| -57% | -$4M |
|
|
XLRN
268
DELISTED
Acceleron Pharma
XLRN
| $2.24M | 0.02% |
13,030
-39,264
| -75% | -$5.14M |
|
269
Adaptive Biotechnologies
ADPT
$3.59B
| $2.23M | 0.02% |
65,590
-37,296
| -36% | -$1.35M |
|
|
PLAN
270
DELISTED
Anaplan, Inc.
PLAN
| $2.12M | 0.02% |
+34,849
| New | +$2.07M |
|
|
AYX
271
DELISTED
Alteryx Inc
AYX
| $1.74M | 0.01% |
23,767
-242,999
| -91% | -$18.3M |
|
272
Porch Group
PRCH
$1.64B
| $1.71M | 0.01% |
96,544
-593,960
| -86% | -$11.1M |
|
273
Nektar Therapeutics
NKTR
$2.39B
| $1.69M | 0.01% |
6,253
-1,538
| -20% | -$370K |
|
|
ZEN
274
DELISTED
ZENDESK INC
ZEN
| $1.56M | 0.01% |
13,377
-22,001
| -62% | -$2.84M |
|
275
Xponential Fitness
XPOF
$273M
| $1.01M | 0.01% |
+79,254
| New | +$920K |
|
Similar funds
HL
DCP
CCM
URS
CIM
MPI
TIM
DPIM
Frontier Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Frontier Capital Management held 297 positions worth $12.7B, down 6.8% from $13.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Frontier Capital Management withdrew a net $911M in Q3 2021, closing 17 positions and reducing 196 holdings. Its most notable exit was FIVE9, an estimated $76.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Frontier Capital Management opened a new position in Commerce.com Inc Series 1 worth $52.6M.
- Frontier Capital Management's largest Q3 2021 buy was Commerce.com Inc Series 1: 1,039,031 shares worth $52.6M.
- Frontier Capital Management added most to Palo Alto Networks in Q3 2021, an estimated $80.6M increase.
- Frontier Capital Management's biggest Q3 2021 reduction was Moderna, cutting an estimated $135M.
- Frontier Capital Management fully exited FIVE9 in Q3 2021, selling an estimated $76.2M.
- Frontier Capital Management's ten largest holdings make up 18% of its $12.7B portfolio in Q3 2021.
- Frontier Capital Management opened 13 new positions and closed 17 in Q3 2021.
- Frontier Capital Management's portfolio value fell 6.8% quarter-over-quarter to $12.7B.
Based on Frontier Capital Management's 13F filing for Q3 2021, filed 19 Oct 2021.